Compare TALK & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TALK | TRNS |
|---|---|---|
| Founded | 2012 | 1964 |
| Country | United States | United States |
| Employees | 598 | N/A |
| Industry | Medical/Nursing Services | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 861.5M |
| IPO Year | N/A | 1995 |
| Metric | TALK | TRNS |
|---|---|---|
| Price | $5.23 | $88.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $6.42 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 2.7M | 168.1K |
| Earning Date | 05-05-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | $26.02 | $21.75 |
| Revenue Next Year | $21.24 | $7.55 |
| P/E Ratio | $155.55 | ★ $155.00 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $2.22 | $50.23 |
| 52 Week High | $5.24 | $94.76 |
| Indicator | TALK | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 49.25 |
| Support Level | $5.19 | $86.10 |
| Resistance Level | $5.23 | $94.36 |
| Average True Range (ATR) | 0.02 | 3.57 |
| MACD | 0.00 | -0.92 |
| Stochastic Oscillator | 72.73 | 30.67 |
Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.